| Tretinoin | Approved Investigational Nutraceutical | MEF2C | 4208 |
downregulated | Tretinoin results in decreased expression of MEF2C mRNA | 5q14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MEF2C | 4208 |
upregulated | Tretinoin results in increased expression of MEF2C mRNA | 5q14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MEGF10 | 84466 |
upregulated | Tretinoin results in increased expression of MEGF10 mRNA | 5q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MEGF6 | 1953 |
downregulated | Tretinoin results in decreased expression of MEGF6 mRNA | 1p36.32 | |
| Tretinoin | Approved Investigational Nutraceutical | MEIOB | 254528 |
downregulated | Tretinoin results in decreased expression of MEIOB mRNA | 16p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MEIS1 | 4211 |
upregulated | Tretinoin results in increased expression of MEIS1 mRNA | 2p14 | |
| Tretinoin | Approved Investigational Nutraceutical | MEIS2 | 4212 |
upregulated | Tretinoin results in increased expression of MEIS2 mRNA | 15q14 | |
| Tretinoin | Approved Investigational Nutraceutical | MEIS3P1 | 4213 |
upregulated | Tretinoin results in increased expression of MEIS3P1 mRNA | 17p12 | |
| Tretinoin | Approved Investigational Nutraceutical | MELTF | 4241 |
downregulated | Tretinoin results in decreased expression of MELTF mRNA | 3q29 | |
| Tretinoin | Approved Investigational Nutraceutical | MELTF | 4241 |
upregulated | Tretinoin results in increased expression of MELTF mRNA | 3q29 | |
| Tretinoin | Approved Investigational Nutraceutical | MEOX1 | 4222 |
upregulated | Tretinoin results in increased expression of MEOX1 mRNA | 17q21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | MEOX2 | 4223 |
upregulated | Tretinoin results in increased expression of MEOX2 mRNA | 7p21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MESP1 | 55897 |
downregulated | Tretinoin results in decreased expression of MESP1 mRNA | 15q26.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MET | 4233 |
upregulated | Tretinoin results in increased expression of MET mRNA | 7q31 | |
| Tretinoin | Approved Investigational Nutraceutical | METRN | 79006 |
upregulated | Tretinoin results in increased expression of METRN mRNA | 16p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | METTL1 | 4234 |
downregulated | Tretinoin results in decreased expression of METTL1 mRNA | 12q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | METTL21A | 151194 |
downregulated | Tretinoin results in decreased expression of METTL21A mRNA | 2q33.3 | |
| Tretinoin | Approved Investigational Nutraceutical | METTL5 | 29081 |
downregulated | Tretinoin results in decreased expression of METTL5 mRNA | 2q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | METTL7A | 25840 |
upregulated | Tretinoin results in increased expression of METTL7A mRNA | 12q13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | METTL8 | 79828 |
downregulated | Tretinoin results in decreased expression of METTL8 mRNA | 2q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MEX3B | 84206 |
upregulated | Tretinoin results in increased expression of MEX3B mRNA | 15q25.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MFAP2 | 4237 |
downregulated | Tretinoin metabolite results in decreased expression of MFAP2 mRNA | 1p36.13 | |
| Tretinoin | Approved Investigational Nutraceutical | MFAP2 | 4237 |
downregulated | Tretinoin results in decreased expression of MFAP2 mRNA | 1p36.13 | |
| Tretinoin | Approved Investigational Nutraceutical | MFAP3 | 4238 |
downregulated | Tretinoin results in decreased expression of MFAP3 mRNA | 5q33.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MFAP3L | 9848 |
downregulated | Tretinoin results in decreased expression of MFAP3L mRNA | 4q33 | |